Straits Times Index
3,176.51 -11.15 (-0.35%) Nikkei
37,068.35 -1,011.35 (-2.66%) Hang Seng
16,224.14 -161.73 (-0.99%) FTSE 100
7,895.85 +18.80 (+0.24%) Bitcoin USD
63,998.56 +2,108.55 (+3.41%) CMC Crypto 200
1,371.97 +59.34 (+4.52%)
Bruker Corporation (BRKR)
After hours:
| Previous close | 78.56 |
| Open | 78.66 |
| Bid | 74.78 x 100 |
| Ask | 77.76 x 200 |
| Day's range | 77.28 - 79.45 |
| 52-week range | 53.79 - 94.86 |
| Volume | |
| Avg. volume | 793,828 |
| Market cap | 10.705B |
| Beta (5Y monthly) | 1.18 |
| PE ratio (TTM) | 26.81 |
| EPS (TTM) | 2.90 |
| Earnings date | 02 May 2024 - 06 May 2024 |
| Forward dividend & yield | 0.20 (0.25%) |
| Ex-dividend date | 29 Feb 2024 |
| 1y target est | 88.40 |
ZacksBruker (BRKR) Introduces Magnet Technology for NMR Adoption
Bruker's (BRKR) latest novel technology facilitates the widespread application of NMR in academic basic and clinical research.
Business WireBruker Introduces Novel NMR Scientific Capabilities for Structural Biology Discoveries in Membrane Proteins and Protein Aggregates
ASILOMAR, Calif., April 08, 2024--Bruker Corporation (Nasdaq: BRKR), the leading provider of nuclear magnetic resonance (NMR) spectroscopy solutions, announces the introduction of novel high-resolution solid-state NMR scientific capabilities that can enable unprecedented structural biology discoveries in large proteins, membrane proteins and in protein aggregates.
Business WireBruker Advances Magnet Technology for Broader Adoption of NMR in Academic and Biopharma Research, and Process Analytical Technologies
ASILOMAR, Calif., April 08, 2024--Bruker Corporation (Nasdaq: BRKR), the leading provider of nuclear magnetic resonance (NMR) systems, today announces novel magnet technology and analytical solutions to support broad adoption of NMR in academic basic and clinical research, as well as in biopharma drug discovery, development and process analytical technologies (PAT).
